Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LGLL - Large Granular Lymphocytic Leukemia”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Early research (Phase 1)Study completedNCT05225584
What this trial is testing

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Who this might be right for
Non Hodgkin Lymphoma (NHL)Peripheral T-cell Lymphoma (PTCL)Cutaneous T-Cell Lymphoma (CTCL)+3 more
Kymera Therapeutics, Inc. 56
Not applicableLooking for participantsNCT05978141
What this trial is testing

A Registry for People With T-cell Lymphoma

Who this might be right for
T-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+28 more
Memorial Sloan Kettering Cancer Center 1,000
Very early researchEnded earlyNCT05316116
What this trial is testing

Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)

Who this might be right for
Large Granular Lymphocyte Leukemia
H. Lee Moffitt Cancer Center and Research Institute 6
Testing effectiveness (Phase 2)Looking for participantsNCT06530576
What this trial is testing

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Who this might be right for
T-LGL LeukemiaNK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05141682
What this trial is testing

Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocyte Leukemia
Jonathan Brammer 11
Testing effectiveness (Phase 2)Ended earlyNCT01191749
What this trial is testing

Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Looking for participantsNCT05475925
What this trial is testing

DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Who this might be right for
LGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell LymphomaPrimary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma+10 more
Dren Bio 200
Large-scale testing (Phase 3)UnknownNCT04453345
What this trial is testing

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Who this might be right for
T-LGL LeukemiaClpd-Nk
Institute of Hematology & Blood Diseases Hospital, China 42
Testing effectiveness (Phase 2)Ended earlyNCT00278265
What this trial is testing

Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic Leukemia
German CLL Study Group 12
Testing effectiveness (Phase 2)Study completedNCT00031980
What this trial is testing

Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer

Who this might be right for
AnemiaLeukemiaNeutropenia+1 more
Alliance for Clinical Trials in Oncology 30
Testing effectiveness (Phase 2)Looking for participantsNCT06530550
What this trial is testing

PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 51
Early research (Phase 1)Ended earlyNCT00671112
What this trial is testing

Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma

Who this might be right for
714leukemiaLymphoma
Brian Hill, MD, PhD 30
Testing effectiveness (Phase 2)Looking for participantsNCT05592015
What this trial is testing

Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocyte Leukemia
Jonathan Brammer 30
Early research (Phase 1)Study completedNCT00001533
What this trial is testing

Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine

Who this might be right for
AnemiaLeukemia, T-CellLymphocytosis+2 more
National Heart, Lung, and Blood Institute (NHLBI) 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05532722
What this trial is testing

ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

Who this might be right for
T-cell Large Granular Lymphocytic Leukemia
Abcuro, Inc. 21
Testing effectiveness (Phase 2)Ended earlyNCT00363779
What this trial is testing

Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia

Who this might be right for
Large Granular Lymphocytic LeukemiaLGL Leukemia
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Looking for participantsNCT06716658
What this trial is testing

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia+7 more
Institute of Hematology & Blood Diseases Hospital, China 48
Not applicableLooking for participantsNCT02863692
What this trial is testing

Registry of the German CLL Study Group

Who this might be right for
CLLSLLHCL+5 more
German CLL Study Group 8,000
Early research (Phase 1)Study completedNCT00076180
What this trial is testing

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic LeukemiaLeukemia, T-Cell Large Granular Lymphocytic
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)UnknownNCT02742727
What this trial is testing

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Who this might be right for
Acute Myeloid LeukemiaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaT-cell Prolymphocytic Leukemia+6 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Load More Results